Zhejiang East Asia Pharmaceutical Co., Ltd. (SHA:605177)
24.89
+0.19 (0.77%)
Sep 23, 2026, 3:00 PM CST
SHA:605177 Market Cap
SHA:605177 has a market cap or net worth of 2.8 billion as of September 23, 2026. Its market cap has increased by 30.31% in one year.
Market Cap
2.80B
Enterprise Value
3.32B
Revenue
990.47M
Ranking
n/a
PE Ratio
n/a
Stock Price
24.89
ChartMarket Cap Chart
Since November 25, 2020, SHA:605177's market cap has decreased from 5.09B to 2.80B, a decrease of -44.99%. That is a compound annual growth rate of -9.74%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 2.80B | 39.82% |
| Dec 31, 2025 | 2.00B | -9.67% |
| Dec 31, 2024 | 2.22B | -26.27% |
| Dec 29, 2023 | 3.01B | 32.27% |
| Dec 30, 2022 | 2.27B | -27.57% |
| Dec 31, 2021 | 3.14B | -22.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Guanhao Biotech | 3.19B |
| Beijing Kawin Technology Share-Holding | 3.05B |
| Baolingbao Biology | 3.02B |
| Zhejiang Shouxiangu Pharmaceutical | 2.96B |
| Hubei Goto Biopharm Group | 2.96B |
| Guangdong VTR Bio-Tech | 2.76B |
| Yantai Zhenghai Biotechnology | 2.76B |
| Shenzhen Bioeasy Biotechnology | 2.71B |